Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,020 signal articles · 243 in last 24h · 119,314 total before filter · latest 24m ago
243last 24h
1534last 7d
256● bullish (7d)
158● bearish (7d)
205publishers
AllMacro291Earnings614M&A106Regulatory20Product13Analyst21
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Bloomberg14d agoneutral
Microsoft’s AI Sales Mostly Come From OpenAI, Disclosures Show

(Bloomberg) -- Microsoft Corp. generates most of its artificial intelligence revenue from OpenAI, according to new disclosures from the company. Most Read from BloombergSpaceX’s AI Splurge Puts a Damper on First Earnings After IPOIran Says Agreement on Hormuz Shipping Reached With OmanTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallThe software giant recorded $2

One Stop Systems Q2 Earnings Call Highlights
MarketBeat14d agoneutral
One Stop Systems Q2 Earnings Call Highlights

One Stop Systems (NASDAQ:OSS) reported second-quarter 2026 revenue growth of 62.3% from continuing operations and raised its full-year revenue growth outlook, citing record bookings, expanding customer relationships and increased demand for ruggedized artificial intelligence and high-performance com

Bloomberg14d agoneutral
Ares Eyes $2 Billion Loan Deal in Slow Year for Private Credit

(Bloomberg) -- Ares Management Corp. is leading a $2.2 billion direct loan to help finance a healthcare services acquisition, in one of the biggest deals since the private credit market was roiled by record redemptions this year.Most Read from BloombergSpaceX’s AI Splurge Puts a Damper on First Earnings After IPOTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallBe

SpaceX shares tumble despite earnings beat
CoinDesk14d agoneutralVIDEO
SpaceX shares tumble despite earnings beat

SpaceX reported its first quarterly results as a public company, beating on revenue but falling 11% as investors focused on heavy capital spending. Its 18,712 bitcoin lost roughly $195 million in value during the quarter. CoinDesk's Jennifer Sanasie hosts "CoinDesk Daily."

Big Tech's blowout profits hide an uncomfortable truth
TheStreet14d agoneutral
Big Tech's blowout profits hide an uncomfortable truth

Big Tech just closed out its second-quarter 2026 earnings season, and the results looked, on paper, like a triumph. Microsoft, Amazon, and Alphabet all posted numbers that blew past Wall Street's estimates, and headlines celebrated growth rates that haven't been seen in years. Dig one layer deeper, ...

💬 Money Quote: Novo Nordisk CEO
The Wall Street Journal14d agoneutral
💬 Money Quote: Novo Nordisk CEO

📣"I don't know the needs of the two competitors that are right now trying to talk to each other, but we don't see a need for a transformative M&A right now." —Mike Doustdar, CEO of Ozempic maker Novo Nordisk in an interview with the Journal, referring to a recent Financial Times report that AstraZeneca and Bristol Myers Squibb held talks over a tie-up.

How Disney's IP Strategy Is Driving Growth
Bloomberg14d agoneutralVIDEO
How Disney's IP Strategy Is Driving Growth

Disney's latest earnings beat was powered by more than just streaming. Phillips Securities analyst Helena Wang joins Bloomberg to explain why Disney's unique ability to monetize its intellectual property across movies, Disney+, theme parks, cruises and consumer products continues to set it apart, and why the company is now adapting that strategy for the TikTok era. She joins Ed Ludlow on "Bloomberg Tech."

Popular crypto stock sinks after disappointing Q2 earnings
TheStreet14d agoneutral
Popular crypto stock sinks after disappointing Q2 earnings

Galaxy Digital (GLXY) shares fell more than 11% on Aug. 5 after the crypto financial services firm reported a second-quarter net loss of $85 million, weighed down by falling digital asset prices despite continued expansion of its artificial intelligence infrastructure business. The company posted ...

Kymera Therapeutics Q2 Earnings Call Highlights
MarketBeat14d agoneutral
Kymera Therapeutics Q2 Earnings Call Highlights

Kymera Therapeutics (NASDAQ:KYMR) said it completed enrollment in its Phase 2b atopic dermatitis trial of KT-621 about six months ahead of schedule, positioning the company to report top-line data by the end of 2026 and potentially begin Phase 3 development around mid-2027. Chief Executive Officer